Michael B Holmes
Examiner (ID: 11288, Phone: (571)272-3686 , Office: P/2129 )
Most Active Art Unit | 2129 |
Art Unit(s) | 2126, 2125, 2122, 2129, 2121 |
Total Applications | 1897 |
Issued Applications | 1641 |
Pending Applications | 93 |
Abandoned Applications | 163 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18252649
[patent_doc_number] => 20230079688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => Methods for monitoring physiological status of a body organ
[patent_app_type] => utility
[patent_app_number] => 18/057912
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057912 | Methods for monitoring physiological status of a body organ | Nov 21, 2022 | Pending |
Array
(
[id] => 18336448
[patent_doc_number] => 20230128397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Prevention and treatment of bone and cartilage damage or disease
[patent_app_type] => utility
[patent_app_number] => 17/978300
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978300 | Prevention and treatment of bone and cartilage damage or disease | Oct 31, 2022 | Pending |
Array
(
[id] => 18221622
[patent_doc_number] => 20230060616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => MEDIA FOR CULTURING STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/971677
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971677
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971677 | MEDIA FOR CULTURING STEM CELLS | Oct 23, 2022 | Pending |
Array
(
[id] => 18344918
[patent_doc_number] => 20230133028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => TRANSGENIC MICE
[patent_app_type] => utility
[patent_app_number] => 18/047673
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047673
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047673 | TRANSGENIC MICE | Oct 18, 2022 | Pending |
Array
(
[id] => 18376252
[patent_doc_number] => 20230151335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 17/958816
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958816 | METHODS AND PRODUCTS FOR TRANSFECTION | Oct 2, 2022 | Pending |
Array
(
[id] => 19324863
[patent_doc_number] => 12042516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Therapy for polyglutamine (polyQ) diseases
[patent_app_type] => utility
[patent_app_number] => 17/957598
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 44
[patent_no_of_words] => 6292
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957598 | Therapy for polyglutamine (polyQ) diseases | Sep 29, 2022 | Issued |
Array
(
[id] => 18255834
[patent_doc_number] => 20230082873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => MICROFLUIDIC DEVICE, SYSTEM AND METHODS THEREOF FOR MEASURING AND RECORDING ELECTRICAL SIGNALS FROM A POOL OF MULTIPLE NEMATODES
[patent_app_type] => utility
[patent_app_number] => 17/947846
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947846 | MICROFLUIDIC DEVICE, SYSTEM AND METHODS THEREOF FOR MEASURING AND RECORDING ELECTRICAL SIGNALS FROM A POOL OF MULTIPLE NEMATODES | Sep 18, 2022 | Pending |
Array
(
[id] => 18985601
[patent_doc_number] => 20240057570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK
[patent_app_type] => utility
[patent_app_number] => 17/933367
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/933367 | EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK | Sep 18, 2022 | Pending |
Array
(
[id] => 18871392
[patent_doc_number] => 11859181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => RNA-guided nucleases and active fragments and variants thereof and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/823897
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74606
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823897 | RNA-guided nucleases and active fragments and variants thereof and methods of use | Aug 30, 2022 | Issued |
Array
(
[id] => 18077732
[patent_doc_number] => 20220403344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS FOR REPROGRAMMING SOMATIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/898360
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898360 | Methods for reprogramming somatic cells | Aug 28, 2022 | Issued |
Array
(
[id] => 18537840
[patent_doc_number] => 20230242943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/821298
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821298 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | Aug 21, 2022 | Pending |
Array
(
[id] => 18198284
[patent_doc_number] => 20230051803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => ASSESSING RETINAL PIGMENT EPITHELIAL CELL POPULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/883263
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/883263 | ASSESSING RETINAL PIGMENT EPITHELIAL CELL POPULATIONS | Aug 7, 2022 | Pending |
Array
(
[id] => 18167281
[patent_doc_number] => 20230033888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/817966
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817966 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | Aug 4, 2022 | Pending |
Array
(
[id] => 18056474
[patent_doc_number] => 20220387560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
[patent_app_type] => utility
[patent_app_number] => 17/816367
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816367 | Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease | Jul 28, 2022 | Pending |
Array
(
[id] => 18108134
[patent_doc_number] => 20230001014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/805825
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17805825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/805825 | DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS | Jun 6, 2022 | Pending |
Array
(
[id] => 18319256
[patent_doc_number] => 20230117384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/750705
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750705 | COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY | May 22, 2022 | Pending |
Array
(
[id] => 17838094
[patent_doc_number] => 20220275399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Adeno-Associated Virus Virions for Treatment of Epilepsy
[patent_app_type] => utility
[patent_app_number] => 17/732901
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732901 | Adeno-Associated Virus Virions for Treatment of Epilepsy | Apr 28, 2022 | Pending |
Array
(
[id] => 17804987
[patent_doc_number] => 20220256822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES
[patent_app_type] => utility
[patent_app_number] => 17/661097
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661097
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/661097 | GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES | Apr 27, 2022 | Pending |
Array
(
[id] => 17792412
[patent_doc_number] => 20220251503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS
[patent_app_type] => utility
[patent_app_number] => 17/730099
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730099 | ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS | Apr 25, 2022 | Pending |
Array
(
[id] => 19106019
[patent_doc_number] => 11959104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Methods of differentiating stem cell-derived ectodermal lineage precursors
[patent_app_type] => utility
[patent_app_number] => 17/712785
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 117
[patent_no_of_words] => 30702
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712785 | Methods of differentiating stem cell-derived ectodermal lineage precursors | Apr 3, 2022 | Issued |